Lobbying Filing Details

Total Spending

$50,000

Activities

2

Lobbyists

4

Gov't Entities

4

Filing Information
Filing UUID:
306ddec0-7d78-4580-8caf-6ab0bb1a5efc
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 8:15 PM
Income:
$50,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
TODD STRATEGY GROUP

​Government Affairs Consulting Firm.

Washington, District of Columbia
Client
MERCK & CO., INC.

Pharmaceutical Company.

District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues.

Lobbyists (4)
  • DANIEL M TODD
  • PAUL EDATTEL
  • NICHOLAS UEHLECKE
  • ERIC BERGREN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Drug Pricing. S.864: HELP Copays Act.

Lobbyists (4)
  • DANIEL M TODD
  • PAUL EDATTEL
  • NICHOLAS UEHLECKE
  • ERIC BERGREN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.